Genomics

Genomic Diagnostics Company, Veracyte to Present at Conferences

Veracyte

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, announced today that Bonnie H. Anderson, chairman, chief executive officer and incoming executive chairman, and Marc Stapley, incoming chief executive officer, are scheduled to participate in two upcoming virtual investor conferences:

  • William Blair Growth Stock Conference
    Fireside Chat on Tuesday, June 1, 2021, at 11:20 a.m. Central Time
  • Jefferies Virtual Healthcare Conference
    Presentation on Friday, June 4, 2021, at 11:30 a.m. Eastern Time

Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days following the conclusion of each live presentation broadcast.

For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.

Business Wire

Business Wire is a trusted source for news organizations, journalists, investment professionals and regulatory authorities, delivering news directly into editorial systems and leading online news sources via its multi-patented NX Network. Business Wire has 18 newsrooms worldwide to meet the needs of communications professionals and news media.

Related posts

GTG to form Strategic Alliance with global testing leader QIAGEN

GlobeNewswire

Bluestar Genomics to Participate in the Goldman Sachs 2022 Conference

Business Wire

Sampled Named “Next-Generation Sequencing ProLab” for Twist Bioscience

Business Wire